6. Contemplating what we have heard today, what do we think we know about what works and what does not, and what would be the most useful things that could/should happen next?
GENERAL DISCUSSION and CHAIRMAN'S SUMMARY
Tuesday, February 11th
8:30 MEETING RESUMES
ELEMENT 4: Discussion Panel, FDA and Industry Representatives
7. Current Legal/Regulatory Issues Around Development of Drugs and Vaccines for Emerging Infections
From the Food and Drug Administration:
From the Forum on Emerging Infections: Member Representatives from Industry